2023年
20230213 核酸药物研究进展-毛奇seminar
20230220 细菌中的蛋白表达-凌月雷seminar
20230227 小分子靶向降解剂RIPTAC-宋世伟seminar
20230306 商业脂质体产品总结-王浩seminar
20230313 HER2靶向性抗体-徐若琳seminar
20230323 真核哺乳动物细胞瞬转-PEI转染-刘亚辉seminar
20230327 流式细胞术-陈思怡seminar
20230403 构建稳定细胞系-井维娜seminar
20230410 质谱的原理及其应用-彭磊seminar
20230417 Fcab to mAb2 基于Fc的抗体药物平台-郑岩seminar
20230424 稳定态细胞的筛选-杨宛榕seminar
20230508 重组蛋⽩表达与纯化的⼀般流程& siRNA放⼤⽣产的新技术-BOOST毛奇seminar
20230515 The Next Generation of Radiopharmaceuticals in PDRadiopharma-凌月雷seminar
20230522 Bicycle Threapeutics- 宋世伟
20230601 糖基化修饰-王浩seminar
20230612 scFv稳定性改进-刘亚辉seminar
20230619 ALN-VSP02 phase 1 trial update 陈思怡seminar
20230624 胰高血糖素样肽-井维娜seminar
20230213 核酸药物研究进展-毛奇seminar
20230220 细菌中的蛋白表达-凌月雷seminar
20230227 小分子靶向降解剂RIPTAC-宋世伟seminar
20230306 商业脂质体产品总结-王浩seminar
20230313 HER2靶向性抗体-徐若琳seminar
20230323 真核哺乳动物细胞瞬转-PEI转染-刘亚辉seminar
20230327 流式细胞术-陈思怡seminar
20230403 构建稳定细胞系-井维娜seminar
20230410 质谱的原理及其应用-彭磊seminar
20230417 Fcab to mAb2 基于Fc的抗体药物平台-郑岩seminar
20230424 稳定态细胞的筛选-杨宛榕seminar
20230508 重组蛋⽩表达与纯化的⼀般流程& siRNA放⼤⽣产的新技术-BOOST毛奇seminar
20230515 The Next Generation of Radiopharmaceuticals in PDRadiopharma-凌月雷seminar
20230522 Bicycle Threapeutics- 宋世伟
20230601 糖基化修饰-王浩seminar
20230612 scFv稳定性改进-刘亚辉seminar
20230619 ALN-VSP02 phase 1 trial update 陈思怡seminar
20230624 胰高血糖素样肽-井维娜seminar
2022年
20220106 PCR在分子克隆中的应用-刘亚辉seminar
20220113 如何递送核酸进细胞liposome-隋韶伟seminar
20220217 siRNA靶向配体偶联物-王浩seminar
20220224 抗体偶联药物的偶联技术-宋世伟seminar
20220303 抗体筛选技术-凌月雷seminar
20220310 抗体-免疫学中的应用-徐若琳seminar
20220317 双特异性抗体-彭磊seminar
20220324 FDA批准的四个siRNA 药物-陈思怡seminar
20220331 ADCs在实体瘤中上市药物概述-郑岩seminar
20220404 Payload in Antibodydrug Conjugates-宋嘉杰seminar
20220414 固相有机合成-井维娜seminar
20220421 偶联药物的进展-宋世伟seminar
20220428 脂质体的修饰和临床药物-隋韶伟seminar
20220512 GalNAc-siRNA-王浩seminar
20220519 外泌体载体开发-细胞质递送-刘亚辉seminar
20220526 Crispr tool kits-凌月雷seminar
20220602 ADCs that target HER2 positive cells-徐若琳seminar
20220616 Linkers in antibody drug conjugates-彭磊seminer
20220623 Antibody-siRNA conjugates-陈思怡seminar
20220630 针对叶酸受体药物临床研发概况-郑岩seminar
20220707 Inhibitors of Carbonic Anhydrase IX-宋嘉杰seminar
20220714 胞质蛋白递送&细胞穿膜肽-井维娜seminar
20220908 PROTAC&PROTAC偶联药物-宋世伟seminar
20220915 单克隆抗体药物的药代动力学特征-隋韶伟seminar
20220922 Fc-FcRn-凌月雷seminar
20220929 Carbonic anhydrase CAIX-王浩seminar
20221006 Chugai Pharma-Main Antibody Engineering Technology-徐若琳seminar
20221013 外泌体疗法-下一代疗法-刘亚辉seminar
20221103 Antibody Fragmentdrug Conjugates-宋嘉杰seminar
20221110 Bicycles bicylic peptide-陈思怡seminar
20221117 蛋白表达流程-井维娜seminar
20221124 Immune Checkpoint-杨宛榕
20221208 BT5528 an EphA2 targeting bicycle peptide-郑岩seminar
20220106 PCR在分子克隆中的应用-刘亚辉seminar
20220113 如何递送核酸进细胞liposome-隋韶伟seminar
20220217 siRNA靶向配体偶联物-王浩seminar
20220224 抗体偶联药物的偶联技术-宋世伟seminar
20220303 抗体筛选技术-凌月雷seminar
20220310 抗体-免疫学中的应用-徐若琳seminar
20220317 双特异性抗体-彭磊seminar
20220324 FDA批准的四个siRNA 药物-陈思怡seminar
20220331 ADCs在实体瘤中上市药物概述-郑岩seminar
20220404 Payload in Antibodydrug Conjugates-宋嘉杰seminar
20220414 固相有机合成-井维娜seminar
20220421 偶联药物的进展-宋世伟seminar
20220428 脂质体的修饰和临床药物-隋韶伟seminar
20220512 GalNAc-siRNA-王浩seminar
20220519 外泌体载体开发-细胞质递送-刘亚辉seminar
20220526 Crispr tool kits-凌月雷seminar
20220602 ADCs that target HER2 positive cells-徐若琳seminar
20220616 Linkers in antibody drug conjugates-彭磊seminer
20220623 Antibody-siRNA conjugates-陈思怡seminar
20220630 针对叶酸受体药物临床研发概况-郑岩seminar
20220707 Inhibitors of Carbonic Anhydrase IX-宋嘉杰seminar
20220714 胞质蛋白递送&细胞穿膜肽-井维娜seminar
20220908 PROTAC&PROTAC偶联药物-宋世伟seminar
20220915 单克隆抗体药物的药代动力学特征-隋韶伟seminar
20220922 Fc-FcRn-凌月雷seminar
20220929 Carbonic anhydrase CAIX-王浩seminar
20221006 Chugai Pharma-Main Antibody Engineering Technology-徐若琳seminar
20221013 外泌体疗法-下一代疗法-刘亚辉seminar
20221103 Antibody Fragmentdrug Conjugates-宋嘉杰seminar
20221110 Bicycles bicylic peptide-陈思怡seminar
20221117 蛋白表达流程-井维娜seminar
20221124 Immune Checkpoint-杨宛榕
20221208 BT5528 an EphA2 targeting bicycle peptide-郑岩seminar